within Pharmacolibrary.Drugs.ATC.J;

model J01GB06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.05333333333333334,
    adminDuration  = 600,
    adminMass      = 0.5,
    adminCount     = 1,
    Vd             = 0.017,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Amikacin is an aminoglycoside antibiotic primarily used for the treatment of severe Gram-negative bacterial infections, including infections caused by multidrug-resistant organisms. It is usually reserved for hospital-acquired infections or when other antibiotics are ineffective. Amikacin is an approved drug and is included in the World Health Organization's List of Essential Medicines.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for adult subjects with normal renal function following single intravenous bolus dose administration.</p><h4>References</h4><ol><li><p>Paegelow, JL, et al., &amp; Holbrook, TC (2024). Pharmacokinetics of amikacin after intravenous, intra-articular, and combined intravenous and intra-articular administration in healthy neonatal foals. <i>Journal of veterinary internal medicine</i> 38(3) 1825–1834. DOI:<a href=&quot;https://doi.org/10.1111/jvim.17087&quot;>10.1111/jvim.17087</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38647141/&quot;>https://pubmed.ncbi.nlm.nih.gov/38647141</a></p></li><li><p>Medellín-Garibay, SE, et al., &amp; García, B (2022). Amikacin pharmacokinetics in elderly patients with severe infections. <i>European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</i> 175 106219–None. DOI:<a href=&quot;https://doi.org/10.1016/j.ejps.2022.106219&quot;>10.1016/j.ejps.2022.106219</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35618200/&quot;>https://pubmed.ncbi.nlm.nih.gov/35618200</a></p></li><li><p>Kilcoyne, I, et al., &amp; Nottle, BF (2023). Effects of a 10% dimethyl sulfoxide solution on radiocarpal joint amikacin pharmacokinetics during intravenous regional limb perfusion in standing sedated horses. <i>Veterinary surgery : VS</i> 52(8) 1171–1179. DOI:<a href=&quot;https://doi.org/10.1111/vsu.13973&quot;>10.1111/vsu.13973</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37280731/&quot;>https://pubmed.ncbi.nlm.nih.gov/37280731</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J01GB06;
